mechanisms underlying globular AβP induced vascular toxicity.
Using several methodological approaches we have observed that in vascular tissues globular AβP is unable to induce oxidative stress, one of the mechanisms hypothesized involved in β−amyloid toxicity. More important, we have demonstrated that globular AβP is able to localize on vascular endothelium where it inhibits eNOS enzymatic activity. In particular, AβP enhances eNOS phosphorylation on Threonin . In fact, selective inhibition of the calcium dependent group of PKC (cPKC) is able to rescue β-amyloid-induced alteration of eNOS phosphorylation, NO production and endothelial vasorelaxation. The activation of these Ca 2+ dependent pathways is likely due to the ability of AβP to evoke Ca 2+ leakage from IP3 receptors on endoplasmic reticulum.
Our data demonstrate that globular AβP induced endothelial NO dysfunction can be attributed to an alteration of intracellular Ca 2+ homeostasis which could lead to the activation of cPKC with consequently change of eNOS phosphorylation pattern. These mechanisms could contribute to shed further light on the toxic effect of β−amyloid in vascular tissues.
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Soluble AβP impairs endothelial function
Alzheimer's disease (AD) is a progressive neurodegenerative disorder characterized by irreversible cognitive and physical deterioration. It is a major cause of death and a growing public health problem as life expectancy in the general population increases (1) .
Typical features of AD are the senile plaques present in the brain, cerebral blood vessels and other tissues (2) . The plaques are composed mainly of fibrillar amyloid β peptides (AβP) generated from the amyloid precursor protein (APP), a ubiquitously expressed transmembrane glycoprotein. The amyloid peptides, constituted primarily of 39 to 42 residues (AβP1-39, 1-40, , are released continuously during cellular metabolism. These peptides circulate in soluble globular form in bloodstream (3) (4) and accumulate on vascular wall of AD patients (5) . In the brain, soluble β-amyloid monomers are able to deposite and transform into insoluble and fibrillar aggregates, forming amyloid plaques (6-7).
Although AD has been considered for long to be of non-vascular origin, a growing body of recent studies has indicated the possibility that vascular risk factors could be involved in the pathophysiology of AD (8) . In particular, patients with AD have morphological alterations of the cerebral vasculature, reduced cerebral blood flow and increased permeability of blood brain barrier, which mainly depends on endothelial function (9) . Furthermore, it has been shown that the fibrillar form of AβP is able to produce a severe damage of the endothelial lining with deleterious effects on endothelial nitric oxide (NO) function (10) (11) (12) . This effect of the fibrillar form of AβP has been attributed to an enhanced NO catabolism due to an increased production of reactive oxygen species (ROS) (13) (14) , since superoxide scavengers are able to prevent fibrillar AβP induced endothelial toxicity (11, 15) . Recent data indicate that also the circulating form of AβP is able to provoke endothelial NO dysfunction, but it is still unclear whether this alteration is oxidative stress-dependent.
On the other hand, a recent study suggests that the soluble form of AβP could exert its deleterious effect on endothelial NO inhibiting nitric oxide synthase enzymatic activity (16 stock solution (0,5 mg/ml) was prepared by dissolving the peptides in deionized water and stored as aliquots at -20°C until used.
Experimental animals.
Experiments were conducted in male Wistar Kyoto rats (Charles River Laboratory) 10-14 weeks old. All experimental procedures were in accordance with guidelines for research in animals of our institution.
Vascular reactivity studies
Vascular reactivity studies have been performed on aortas as previously described (17) .
Vasorelaxation to Acetylcholine (Sigma, ACh, 10 mol/L AβP, were tested. seconds of light exposure. The images were then merged so that the 515nm-emitted fluorescence due to DAF appeared green above a purple all-wavelengths-emitted autofluorescence background derived from the fibers of the vessel. Green fluorescence intensity was quantified using the imaging software. 14 C-citrulline was eluted twice with 2ml of water and radioactivity was determined by scintillation counting.
Measurement of ex vivo aortic
Analysis of AβP localization
Analysis of eNOS phosphorylation pattern
After isolation and treatment with AβP (1µM, 1h) and/or ACh (1µM, 10min) and/or Gö6976 (2µM, 15min, Calbiochem), proteins were extract as previously described. 20µg of protein extract were subjected to a 10% SDS-PAGE and electroblotted on nitrocellulose membranes, which were blocked at room temperature for 1h in blocking solution (5% milk in 
Analysis of PKC phosphorylation
After isolation and treatment with AβP (1µM, 1h) and/or ACh (1µM, 10min), specimens were lysated as above. 20µg of protein extract were subjected to a 10% SDS-PAGE. Gels were electroblotted on nitrocellulose membrane (BioRad). Membrane was blocked at room temperature for 1h in blocking solution (5% milk in TBS-T), incubated overnight at 4°C with anti-phospho-Ser 660 -PKC (1µg/ml, Cell Signaling). Membrane was incubated with peroxidaseconjugate anti-rabbit antibodies (1:10000, Amersham). Proteins were revealed as above.
Primary and secondary antibodies were completely removed with Stripping Buffer (0.5M NaCl, 0.5M glacial acetic acid) at room temperature for 30min. Membranes were blocked in blocking solution (5% milk in TBS-T) for 1h at room temperature, incubated with anti-PKC (1µg/ml, Transduction Laboratories) for 3h at room temperature, and incubated with peroxidase-conjugate antimouse IgG (1:10000 in TBS-T). Proteins were revealed as above.
The intensity of the bands was quantified as described. 
Analysis of Calcium release in endothelial cells
RESULTS
Soluble AβP induces endothelial NO dysfunction
Soluble AβP was able to attenuate ACh induced dose-dependent vasodilatation on rat aorta, although had no effect on basal vascular tone. In contrast, AβP did not influence vasodilatation evoked by SNP (Fig. 1A-C) indicating that globular AβP impaired endothelial NO function, but not vascular smooth muscle sensitivity to NO. Moreover, in a vessel of the cerebral district, such as basilar artery, we observed that AβP was able to attenuate the vasodilation induced by SubP, a potent nitric oxide stimulus on cerebral arteries (Fig 1B) .
Finally, soluble AβP was able to attenuate ACh-induced DAF-2 fluorescence while it did not alter basal DAF-2 signal (Fig 1D) .
Soluble AβP does not induce vascular oxidative stress
To explore whether soluble AβP was able to induce endothelial NO dysfunction by enhanced production of ROS, we evaluated vascular O 2 -production by three different methodologies: lucigenin-enhanced chemiluminescence, DHE dyeing and nitrotyrosine detection. All revealed that soluble AβP neither alone nor after incubation with ACh induced ROS production in vessels. Yet, our experimental setting was able to detect oxidative stress evoked by Angiotensin II (AngII), used as positive control ( Fig. 2A-B) . Moreover, preincubation with a ROS scavenger as super oxide dismutase (SOD) was unable to rescue ACh-induced vasodilatation altered by AβP (Fig.1A) suggesting that oxidative stress was not involved in vascular toxicity mediated by the globular form of AβP.
Soluble AβP localizes on vascular endothelium and attenuates eNOS activity.
Our data revealed that biotinylated AβP, but not a different biotinylated scrambled peptide (data not shown), was able to localize mainly on vascular endothelium (Fig 3A) .
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Furthermore, the analysis of the catalytic activity of eNOS on aortic rings showed that soluble AβP, but not scrambled AβP, significantly inhibited the enzymatic activity (Fig 3B) . These results indicate that globular AβP interacts with the endothelial lining where inhibits eNOS enzymatic activity.
Soluble AβP alters eNOS phosphorylation pattern.
Since eNOS activity can be regulated by a coordinated control of enzyme phosphorylation on Serine and Threonine (24), we extended our analysis to these latter. As shown in Fig 4A, .
Soluble AβP alters eNOS phosphorylation pattern and endothelial dysfunction through a cPKC dependent mechanism.
It has been described that eNOS phosphorylation on Thr 495 is mediated by a PKC signaling (27) . To explore the impact of PKC on AβP-induced eNOS phosphorylation pattern we tested the effect of the globular AβP in presence of Bisindolylmaleimide (data not shown), a pan-PKC inhibitor, and of Gö6976, a selective inhibitor of the calcium dependent group of PKC (cPKC). Fig 4A shows , indicating that AβP is unable to evoke its effect on eNOS phosphorylation when the cPKC are inhibited. Finally, the exposure to Gö6976 was also able to rescue the impaired ACh-evoked vasorelaxation observed in presence of AβP (Fig 4B) .
Soluble AβP influences PKC-signaling pathway in vascular tissues.
To further investigate the hypothesis that a PKC-dependent mechanism could be involved in AβP-induced eNOS dysfunction, we analyzed PKC Ser 660 phosphorylation, an activating site of the enzyme, in vascular tissues. We revealed that AβP markedly increased phosphorylation at this site indicating that AβP induces PKC structural modifications necessary to the enzyme to be fully active and suggesting the involvement of PKC in AβP-induced vascular effect (Fig 5) .
Soluble AβP induces Ca 2+ leakage in endothelial cells
To clarify how AβP affects calcium-dependent signaling, we investigated whether AβP alters calcium homeostasis in endothelial cells. AβP induced a slow and progressive increase in intracellular calcium concentration within minutes, lasting for all the period of observation after the addition of the peptide (Fig 6A) , whereas, a scrambled peptide did not induce any variation in intracellular calcium concentration. Moreover, acetylcholine evoked as expected a spike of intracellular calcium, which returned at basal levels after 10 minutes and the same with Ach alone. Finally, in presence of twenty min exposure to a scrambled peptide, Achevoked calcium response was unaffected (Fig 6B) .
Soluble AβP localizes in the perinuclear region of endothelial cells
To explore the mechanisms through which AβP was able to induce intracellular calcium leakage, we analyzed AβP localization in HAEC. 
Soluble AβP induces calcium leakage from IP3 receptors of the endoplasmic reticulum.
In the light of the data described above, we further investigate the effect of AβP on intracellular calcium stores regulated by IP3R. In particular, the calcium release from endoplasmic reticulum evoked by furanophostin, a selective non receptorial IP3R agonist, was significantly blunted by previous exposure to beta-amyloid (Fig.7B ). More important, betaamyloid induced calcium leakage was prevented by the administration of 2APB, a selective IP3R antagonist (Fig.7C ). These data indicate that beta amyloid influences IP3R function with a consequent calcium leakage from intracellular calcium stores. Interestingly, our data demonstrate a defect in NO production in presence of the globular AβP as revealed by an impaired eNOS enzymatic activity, and a concomitant reduced presence of agonist stimulated endothelial NO in both aorta and basilar artery. The fact that basal NO production observed with DAF-2 was not influenced by AβP, and the awareness that the measurement of eNOS activity is performed in a reaction buffer containing all the factors eNOS needs to be fully active, among which the Ca 2+ /calmodulin complex, suggest that AβP-induced eNOS alteration can be observed only when eNOS is stimulated.
Actually, eNOS enzymatic activity is also influenced by its phosphorylation at three or Recent studies have shown that a PKC-dependent signaling pathway is able to increase eNOS Thr 495 phosphorylation (28) and previous observations have shown that AβP is able to induce PKC activation in neuronal cells (29) (30) . Thus, we extended our analysis to clarify whether a PKC-dependent signaling pathway is implicated in AβP induced endothelial dysfunction. We observed that the globular AβP is able to induce PKC phosphorylation on Since it has been reported that AβP is able to elicit calcium current in several cell lines (32), we assessed the involvement of the calcium dependent group of PKC (cPKC) in AβP-induced eNOS dysfunction. In particular, we demonstrated that the use of a selective inhibitor of cPKC is able to rescue β-amyloid impact on eNOS phosphorylation, NO production and endothelial vasorelaxation, narrowing to a cPKC dependent signaling pathway the responsibility of the vascular toxicity induced by the globular form of β-amyloid.
Both eNOS and cPKC signaling tightly depend on intracellular calcium dynamics since eNOS is activated by the Ca 
